Disposition during acute COVID-19 illness | ||||
---|---|---|---|---|
Characteristic | All patients (N = 3792) | No hospitalization (n = 3546) | Hospitalization without ICU admission (n = 164) | ICU admission (n = 82) |
Sex, n (%) | ||||
Female | 1648 (43.5) | 1571 (44.3) | 56 (34.1) | 21 (25.6) |
Male | 2144 (56.5) | 1975 (55.7) | 108 (65.9) | 61 (74.4) |
Age, years | ||||
Mean ± SD | 40.4 ± 12.2 | 39.9 ± 12.2 | 46.4 ± 11.8 | 48.0 ± 10.3 |
Median (Q1; Q3) | 40 (31; 50) | 39 (30; 50) | 47 (36.5; 56) | 50.5 (41; 56) |
Age group, years, n (%) | ||||
18–29 | 859 (22.7) | 838 (23.6) | 15 (9.1) | 6 (7.3) |
30–49 | 1900 (50.1) | 1791 (50.5) | 78 (47.6) | 31 (37.8) |
50–64 | 1033 (27.2) | 917 (25.9) | 71 (43.3) | 45 (54.9) |
Race or ethnicity, n (%) | ||||
White | 1670 (44.0) | 1599 (45.1) | 49 (29.9) | 22 (26.8) |
Black | 397 (10.5) | 359 (10.1) | 21 (12.8) | 17 (20.7) |
Hispanic | 1078 (28.4) | 984 (27.7) | 66 (40.2) | 28 (34.1) |
Asian | 229 (6.0) | 215 (6.1) | 10 (6.1) | 4 (4.9) |
Unknown | 418 (11.0) | 389 (11.0) | 18 (11.0) | 11 (13.4) |
Geographic division, n (%) | ||||
New England | 236 (6.2) | 227 (6.4) | 7 (4.3) | 2 (2.4) |
Mid-Atlantic | 764 (20.1) | 730 (20.6) | 27 (16.5) | 7 (8.5) |
East North Central | 729 (19.2) | 670 (18.9) | 39 (23.8) | 20 (24.4) |
West North Central | 402 (10.6) | 374 (10.5) | 20 (12.2) | 8 (9.8) |
South Atlantic | 664 (17.5) | 617 (17.4) | 33 (20.1) | 14 (17.1) |
East South Central | 93 (2.5) | 87 (2.5) | 4 (2.4) | 2 (2.4) |
West South Central | 330 (8.7) | 305 (8.6) | 14 (8.5) | 11 (13.4) |
Mountain | 295 (7.8) | 285 (8.0) | 5 (3.0) | 5 (6.1) |
Pacific | 252 (6.7) | 236 (6.7) | 10 (6.1) | 6 (7.3) |
Insurance, n (%) | ||||
Commercial | 3756 (99.1) | 3523 (99.4) | 155 (94.5) | 78 (95.1) |
Medicare | 36 (0.9) | 23 (0.6) | 9 (5.5) | 4 (4.9) |
Care setting of COVID-19 diagnosis, n (%) | ||||
Inpatient | 181 (4.8) | 0 (0.0) | 128 (78.0) | 53 (64.6) |
Outpatient | 3611 (95.2) | 3546 (100) | 36 (22.0) | 29 (35.4) |
Disposition during acute COVID-19 illness, n (%) | ||||
No hospitalization | 3546 (93.5) | |||
Hospitalization without ICU admission | 164 (4.3) | |||
ICU admission | 82 (2.2) | |||
COVID-19 inpatient stay that overlaps acute and post-acute phases (> 30 days), n (%) | 9 (0.2) | 0 (0.0) | 2 (1.2) | 7 (8.5) |